High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus

被引：52
|
作者：
Sookoian, S
Neglia, V
Castaño, G
Frider, B
Kien, MC
Chohuela, E
机构：
来源：
ARCHIVES OF DERMATOLOGY | 1999年 / 135卷 / 08期
关键词：
D O I：
10.1001/archderm.135.8.1000
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1000 / 1001
页数：2
相关论文
共 50 条
  • [21] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [22] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    GASTROENTEROLOGY, 2001, 120 (05) : A383 - A383
  • [23] Utility of combination therapy with ribavirin plus interferon on chronic hepatitis C patients previously resistant to interferon.
    Marchi, S
    Ricchiuti, A
    Ciccorossi, P
    Petruccelli, S
    Arpe, P
    Bellini, M
    Costa, F
    Agelli, M
    Maggi, F
    Vatteroni, ML
    Morganti, R
    Pistello, M
    Bendinelli, M
    Maltinti, G
    HEPATOLOGY, 1997, 26 (04) : 1712 - 1712
  • [24] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [25] A randomized study of ribavirin plus interferon alfa vs interferon alfa alone for treatment of patients with chronic hepatitis C
    Lay, CS
    Tsai, YL
    HEPATOLOGY, 1999, 30 (04) : 621A - 621A
  • [26] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or standard combination therapy
    Chousterman, N
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
  • [27] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [28] Interferon alfa/ribavirin combination therapy in mixed hepatitis C virus (HCV) genotype infection
    Khan, AQ
    Khan, FQ
    Iqbal, Q
    Ijaz, A
    Imran, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S115 - S116
  • [29] Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C
    Wirth, S
    Lang, T
    Gehring, S
    Gerner, P
    HEPATOLOGY, 2002, 36 (05) : 1280 - 1284
  • [30] Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients
    Telfer, PT
    Garson, JA
    Whitby, K
    Grant, PR
    Yardumian, A
    Hoffbrand, AV
    Wonke, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) : 850 - 855
12345